{"Symbol": "FWP", "AssetType": "Common Stock", "Name": "Forward Pharma A/S", "Description": "Forward Pharma A/S, a biopharmaceutical company, focuses on developing proprietary formulation of dimethyl fumarate for the treatment of inflammatory and neurological indications. The company was founded in 2005 and is headquartered in Copenhagen, Denmark.", "Exchange": "NASDAQ", "Currency": "USD", "Country": "USA", "Sector": "Healthcare", "Industry": "Biotechnology", "Address": "Oestergade 24A, Copenhagen, Denmark, 1100", "FullTimeEmployees": "5", "FiscalYearEnd": "December", "LatestQuarter": "2019-12-31", "MarketCapitalization": "42936972", "EBITDA": "-7408000", "PERatio": "None", "PEGRatio": "0.13", "BookValue": "11.422", "DividendPerShare": "None", "DividendYield": "0", "EPS": "-0.128", "RevenuePerShareTTM": "0", "ProfitMargin": "0", "OperatingMarginTTM": "0", "ReturnOnAssetsTTM": "-0.0409", "ReturnOnEquityTTM": "-0.0528", "RevenueTTM": "0", "GrossProfitTTM": "0", "DilutedEPSTTM": "-0.622", "QuarterlyEarningsGrowthYOY": "0", "QuarterlyRevenueGrowthYOY": "0", "AnalystTargetPrice": "37", "TrailingPE": "0", "ForwardPE": "0", "PriceToSalesRatioTTM": "0", "PriceToBookRatio": "0.5611", "EVToRevenue": "0", "EVToEBITDA": "6.4512", "Beta": "1.9951", "52WeekHigh": "11.01", "52WeekLow": "0.81", "50DayMovingAverage": "6.4325", "200DayMovingAverage": "6.2931", "SharesOutstanding": "6891970", "SharesFloat": "1120242", "SharesShort": "4727", "SharesShortPriorMonth": "9663", "ShortRatio": "0.08", "ShortPercentOutstanding": "0", "ShortPercentFloat": "0", "PercentInsiders": "0", "PercentInstitutions": "20.493", "ForwardAnnualDividendRate": "0", "ForwardAnnualDividendYield": "0", "PayoutRatio": "0", "DividendDate": "2017-09-11", "ExDividendDate": "2017-09-12", "LastSplitFactor": "1:7", "LastSplitDate": "2019-12-06"}